Ian Hermans

Affiliations: 
University of Oxford, Oxford, United Kingdom 
Google:
"Ian Hermans"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cooney TR, Farrand K, Draper SL, et al. (2023) Synthesis and Biological Evaluation of Peptide-Adjuvant Conjugate Vaccines with Increasing Antigen Content. Bioconjugate Chemistry
Pankhurst TE, Buick KH, Lange JL, et al. (2023) MAIT cells activate dendritic cells to promote T cell differentiation and induce humoral immunity. Cell Reports. 42: 112310
Dasyam N, Sharples KJ, Barrow C, et al. (2023) A randomised controlled trial of long NY-ESO-1 peptide-pulsed autologous dendritic cells with or without alpha-galactosylceramide in high-risk melanoma. Cancer Immunology, Immunotherapy : Cii
Burn OK, Farrand K, Pritchard T, et al. (2022) Glycolipid-peptide conjugate vaccines elicit CD8 T-cell responses and prevent breast cancer metastasis. Clinical & Translational Immunology. 11: e1401
Prasit KK, Ferrer-Font L, Burn OK, et al. (2022) Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect. Oncoimmunology. 11: 2081009
Meijlink MA, Chua YC, Chan STS, et al. (2022) 6″-Modifed α-GalCer-peptide conjugate vaccine candidates protect against liver-stage malaria. Rsc Chemical Biology. 3: 551-560
Burn OK, Pankhurst TE, Painter GF, et al. (2021) Harnessing NKT cells for vaccination. Oxford Open Immunology. 2: iqab013
Jarvis EM, Collings S, Authier-Hall A, et al. (2021) Mucosal-Associated Invariant T (MAIT) Cell Dysfunction and PD-1 Expression in Prostate Cancer: Implications for Immunotherapy. Frontiers in Immunology. 12: 748741
Fu Z, Mowday AM, Smaill JB, et al. (2021) Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy. Cells. 10
Painter GF, Burn OK, Hermans IF. (2021) Using agonists for iNKT cells in cancer therapy. Molecular Immunology. 130: 1-6
See more...